Patent · US Active

Modulators of α7 nicotinic acetylcholine receptors and therapeutic uses thereof

US8163729B2 · kind B2 · utility

0Cited by

29References

19Claims

0Family size

Assignees

Wyeth, LLC · US
SIENA BIOTECH S.P.A. · IT

Inventors

Chiara Ghiron · Siena, IT
Arianna Nencini · Siena, IT
Iolanda Micco · Colle di Val d'Elsa, IT
Riccardo Zanaletti · Verona, IT
Laura Maccari · Arbia, IT
Hendrick Bothmann · Colle di Val d'Elsa, IT
Simon Nicolas Haydar · South San Francisco, US
Maurizio Varrone · Siena, IT
Carmela Pratelli · Siena, IT
Boyd L. Harrison · Cincinnati, US

Key dates

Filing date	Jan 16, 2008
Grant date	Apr 24, 2012
Priority date	—
Expiry date	Jan 16, 2028

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D471/04
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

The present invention provides compounds of formula (I) and compositions thereof, methods of making them, and methods of using them to modulate alpha7 nicotinic acetylcholine receptors and/or to treat any of a variety of disorders, diseases, and conditions. Provided compounds can affect, among other things, neurological, psychiatric and/or inflammatory system.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.